RFG Advisory’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $326K | Buy |
3,418
+232
| +7% | +$22.3K | 0.01% | 921 |
|
|
2026
Q1 | $330K | Buy |
+3,186
| New | +$361K | 0.01% | 870 |
|
|
2025
Q4 | – | Sell |
-1,986
| Closed | -$245K | – | 991 |
|
|
2025
Q3 | $245K | Sell |
1,986
-45
| -2% | -$5.58K | 0.01% | 868 |
|
|
2025
Q2 | $244K | Sell |
2,031
-375
| -16% | -$50K | 0.01% | 843 |
|
|
2025
Q1 | $354K | Buy |
2,406
+290
| +14% | +$44.3K | 0.01% | 673 |
|
|
2024
Q4 | $344K | Sell |
2,116
-1,232
| -37% | -$202K | 0.01% | 616 |
|
|
2024
Q3 | $545K | Buy |
3,348
+11
| +0.3% | +$1.63K | 0.02% | 492 |
|
|
2024
Q2 | $455K | Buy |
3,337
+500
| +18% | +$69.4K | 0.01% | 516 |
|
|
2024
Q1 | $434K | Buy |
2,837
+5
| +0.2% | +$746 | 0.01% | 528 |
|
|
2023
Q4 | $404K | Sell |
2,832
-103
| -4% | -$13.7K | 0.02% | 484 |
|
|
2023
Q3 | $385K | Buy |
2,935
+307
| +12% | +$46.7K | 0.02% | 453 |
|
|
2023
Q2 | $418K | Buy |
2,628
+20
| +0.8% | +$3.23K | 0.02% | 460 |
|
|
2023
Q1 | $413K | Buy |
2,608
+9
| +0.3% | +$1.35K | 0.02% | 449 |
|
|
2022
Q4 | $402K | Buy |
2,599
+13
| +0.5% | +$1.84K | 0.02% | 456 |
|
|
2022
Q3 | $370K | Sell |
2,586
-135
| -5% | -$19.5K | 0.02% | 437 |
|
|
2022
Q2 | $378K | Sell |
2,721
-45
| -2% | -$6.43K | 0.02% | 409 |
|
|
2022
Q1 | $385K | Sell |
2,766
-20
| -0.7% | -$3.06K | 0.02% | 371 |
|
|
2021
Q4 | $486K | Buy |
2,786
+780
| +39% | +$130K | 0.03% | 315 |
|
|
2021
Q3 | $332K | Buy |
2,006
+463
| +30% | +$79.7K | 0.03% | 334 |
|
|
2021
Q2 | $278K | Buy |
1,543
+183
| +13% | +$33.4K | 0.02% | 363 |
|
|
2021
Q1 | $262K | Buy |
1,360
+27
| +2% | +$5.2K | 0.03% | 361 |
|
|
2020
Q4 | $264K | Sell |
1,333
-50
| -4% | -$10.3K | 0.03% | 360 |
|
|
2020
Q3 | $291K | Hold |
1,383
| – | – | 0.04% | 320 |
|
|
2020
Q2 | $303K | Buy |
1,383
+8
| +0.6% | +$1.6K | 0.05% | 286 |
|
|
2020
Q1 | $238K | Buy |
1,375
+49
| +4% | +$8.1K | 0.04% | 296 |
|
|
2019
Q4 | $204K | Sell |
1,326
-12
| -0.9% | -$1.79K | 0.03% | 347 |
|
|
2019
Q3 | $203K | Sell |
1,338
-79
| -6% | -$12.5K | 0.04% | 316 |
|
|
2019
Q2 | $219K | Sell |
1,417
-62
| -4% | -$9.47K | 0.05% | 286 |
|
|
2019
Q1 | $241K | Sell |
1,479
-2,020
| -58% | -$313K | 0.06% | 225 |
|
|
2018
Q4 | $539K | Buy |
3,499
+600
| +21% | +$93.5K | 0.13% | 118 |
|
|
2018
Q3 | $436K | Buy |
2,899
+253
| +10% | +$35.9K | 0.11% | 178 |
|
|
2018
Q2 | $358K | Sell |
2,646
-1,241
| -32% | -$153K | 0.11% | 147 |
|
|
2018
Q1 | $517K | Buy |
3,887
+601
| +18% | +$80.7K | 0.19% | 85 |
|
|
2017
Q4 | $481K | Sell |
3,286
-238
| -7% | -$32.4K | 0.22% | 103 |
|
|
2017
Q3 | $450K | Sell |
3,524
-371
| -10% | -$49.9K | 0.28% | 78 |
|
|
2017
Q2 | $520K | Sell |
3,895
-152
| -4% | -$20.5K | 0.36% | 53 |
|
|
2017
Q1 | $543K | Buy |
4,047
+1,794
| +80% | +$232K | 0.41% | 60 |
|
|
2016
Q4 | $275K | Hold |
2,253
| – | – | 0.26% | 71 |
|
|
2016
Q3 | $275K | Buy |
2,253
+14
| +0.6% | +$1.83K | 0.25% | 72 |
|
|
2016
Q2 | $310K | Sell |
2,239
-172
| -7% | -$22.3K | 0.27% | 69 |
|
|
2016
Q1 | $304K | Buy |
2,411
+506
| +27% | +$64.3K | 0.24% | 71 |
|
|
2015
Q4 | $242K | Buy |
+1,905
| New | +$236K | 0.18% | 48 |
|
Other funds holding CLX
RFG Advisory's CLX Position: Q2 2026 in Review
RFG Advisory increased its Clorox (CLX) stake by 7.3% in Q2 2026, buying an estimated $22.3K and bringing the position to 3,418 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #921.
RFG Advisory first reported a position in CLX in Q4 2015 and has held it in 42 quarters since. The position peaked at $545K in Q3 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- RFG Advisory held 3,418 shares of Clorox worth $326K as of Q2 2026.
- RFG Advisory bought 232 Clorox shares in Q2 2026, an estimated $22.3K.
- Clorox made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #921 holding.
- RFG Advisory first reported a position in Clorox in Q4 2015 and has held it in 42 quarters since.
- RFG Advisory's Clorox position peaked at $545K in Q3 2024.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.